Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)

M. Neil Reaume, Natasha B. Leighl, Nicole Mittmann, Doug Coyle, Vera Hirsh, Lesley Seymour, Dongsheng Tu, Frances A. Shepherd, Barbara Graham, Cesare Gridelli, Francesco Perrone, Massimo Di Maio, Penelope A. Bradbury, William K. Evans

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)'. Together they form a unique fingerprint.

Medicine & Life Sciences